Monica Agarwal, MD
Family Medicine · Glen Burnie, MDNPI 1578850541
Payments from drug & device makers
Across 120 payments — averaging $20.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$434
- Lilly USA, LLC$262
- AstraZeneca$198
- Novo Nordisk$183
- Pfizer$142
- Boehringer Ingelheim$141
- plus $1K from 20 others
What the payments were for
- Food & beverage$2,495100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 24 | $434 |
| Lilly USA, LLC | 12 | $262 |
| AstraZeneca | 9 | $198 |
| Novo Nordisk | 10 | $183 |
| Pfizer | 7 | $142 |
| Boehringer Ingelheim | 7 | $141 |
| Abbott | 6 | $133 |
| Axsome Therapeutics, Inc. | 5 | $122 |
| Lundbeck LLC | 5 | $102 |
| Exact Sciences | 4 | $99 |
| GSK | 4 | $95 |
| Astellas Pharma US Inc | 3 | $77 |
| Sanofi-aventis U.S. LLC | 5 | $76 |
| Corcept Therapeutics | 2 | $53 |
| Amgen(2 entities) | 2 | $48 |
| Neurocrine Biosciences, Inc. | 2 | $43 |
| Johnson & Johnson | 2 | $42 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $37 |
| UCB, Inc. | 1 | $35 |
| Novartis | 1 | $34 |
| Phathom Pharmaceuticals, Inc. | 2 | $30 |
| Daiichi Sankyo Inc. | 1 | $28 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Idorsia Pharmaceuticals US Inc | 1 | $22 |
| Acadia Pharmaceuticals Inc | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
How this compares
$2,495 in reported general payments places this provider in the 80th percentile of 1,193 family medicine providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 14 | $1,482 |
| Atorvastatin Calcium | 82 | $689 |
| Metoprolol Succinate | 44 | $376 |
| Aripiprazole | 13 | $325 |
| Levothyroxine Sodium | 28 | $301 |
| Amlodipine Besylate | 47 | $296 |
| Losartan Potassium | 21 | $239 |
| Fluticasone Propionate | 12 | $215 |
| Rosuvastatin Calcium | 16 | $150 |
| Gabapentin | 22 | $144 |
| Carvedilol | 14 | $143 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 15 | $136 |
| Vitamin D2Ergocalciferol (Vitamin D2) | 16 | $134 |
| Trazodone Hcl | 28 | $133 |
| Pantoprazole Sodium | 15 | $126 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Glen Burnie
- Sharon ChungGlen Burnie$333K
- Stephan IzziGlen Burnie$14K
- Vincent IzziGlen Burnie$13K
- Stephen OngOxon Hill$5.9M
- Stephan BartWoodstock$1.7M
- Karen DonaldsonBaltimore$899K
- Rajiv DuaColumbia$765K
- Greg TampusLutherville Timonium$735K
- Louis JacquesBaltimore$522K
- Stephanie MellerOxon Hill$518K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.